Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biorestorative Therapies Inc (BRTX)

Biorestorative Therapies Inc (BRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 2,275
  • Shares Outstanding, K 22,772
  • Annual Sales, $ 110 K
  • Annual Income, $ -12,520 K
  • 60-Month Beta 0.44
  • Price/Sales 26.67
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.23
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/12/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0800 +24.88%
on 10/08/19
0.2740 -63.54%
on 09/19/19
-0.1600 (-61.56%)
since 09/18/19
3-Month
0.0800 +24.88%
on 10/08/19
0.4200 -76.21%
on 07/31/19
-0.2501 (-71.46%)
since 07/18/19
52-Week
0.0800 +24.88%
on 10/08/19
1.7500 -94.29%
on 10/22/18
-1.5001 (-93.76%)
since 10/18/18

Most Recent Stories

More News
BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award

BioRestorative Therapies, Inc. (the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that a member of the Company's Scientific Advisory Board and its...

BRTX : 0.0999 (-23.15%)
BioRestorative Therapies Comments on Recent Promotional Activity

BioRestorative Therapies, Inc. (the "Company") (OTC: BRTX), a life sciences company focused on stem cell - based therapies, is providing comment on recent promotional activity concerning its shares of...

OTCM : 34.2600 (-0.26%)
BRTX : 0.0999 (-23.15%)
BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome

BioRestorative Therapies, Inc. (the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it has expanded its "off-the-shelf" brown adipose derived...

BRTX : 0.0999 (-23.15%)
BioRestorative Therapies' Stockholders Approve Institutional Investor Agreement and Exchange Agreements

BioRestorative Therapies, Inc. (the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that, at a special meeting of stockholders, the Company's stockholders...

BRTX : 0.0999 (-23.15%)
BioRestorative Therapies Signs $5.4 Million Financing with Institutional Investor

BioRestorative Therapies, Inc. (the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it has entered into a securities purchase agreement with Arena...

BRTX : 0.0999 (-23.15%)
BioRestorative Therapies to Present at the 22nd Annual American Society of Gene and Cell Therapy as to Data on its Platform Technology for the Treatment of Metabolic Disorders

BioRestorative Therapies, Inc. ("BioRestorative" or the "Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that Francisco Silva, Vice President of Research...

BRTX : 0.0999 (-23.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BRTX with:

Key Turning Points

2nd Resistance Point 0.1496
1st Resistance Point 0.1248
Last Price 0.0999
1st Support Level 0.0803
2nd Support Level 0.0606

See More

52-Week High 1.7500
Fibonacci 61.8% 1.1121
Fibonacci 50% 0.9150
Fibonacci 38.2% 0.7179
Last Price 0.0999
52-Week Low 0.0800

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar